Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes

Update Il y a 4 ans
Reference: NCT00974090

Woman and Man

  • | Country :
  • Japan
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to evaluate the safety and efficacy of MP-513 (Teneligliptin) in combination with Sulfonylurea in patients with type 2 Diabetes for 12 weeks administration and to evaluate the safety and efficacy of MP-513 in combination with Sulfonylurea with an extension treatment for up to 52 weeks.


Inclusion criteria

  • Type 2 diabetes mellitus

Links